14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:DRNA
Delisted

Dicerna Pharmaceuticals Stock Price (Quote)

$38.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.22 $38.22 Friday, 27th May 2022 DRNA stock ended at $38.22. During the day the stock fluctuated 0% from a day low at $38.22 to a day high of $38.22.
90 days $38.22 $38.22
52 weeks $19.06 $40.14

Historical Dicerna Pharmaceuticals prices

Date Open High Low Close Volume
Sep 17, 2021 $21.44 $21.63 $20.75 $21.61 2 182 931
Sep 16, 2021 $21.15 $21.50 $20.73 $21.39 385 633
Sep 15, 2021 $21.12 $21.76 $21.09 $21.21 488 453
Sep 14, 2021 $21.28 $21.89 $21.06 $21.14 656 762
Sep 13, 2021 $21.95 $22.11 $20.98 $21.22 670 433
Sep 10, 2021 $21.87 $21.96 $20.78 $21.70 1 424 023
Sep 09, 2021 $22.05 $22.61 $21.56 $21.94 706 245
Sep 08, 2021 $20.64 $22.15 $20.32 $22.05 1 414 977
Sep 07, 2021 $21.30 $22.19 $20.62 $20.68 1 046 841
Sep 03, 2021 $21.16 $21.42 $20.90 $21.24 666 438
Sep 02, 2021 $20.46 $21.50 $20.46 $21.29 1 155 762
Sep 01, 2021 $20.80 $20.98 $20.24 $20.29 910 691
Aug 31, 2021 $21.11 $21.76 $20.47 $20.58 1 813 615
Aug 30, 2021 $20.63 $21.27 $20.31 $20.98 1 423 107
Aug 27, 2021 $20.09 $21.26 $19.94 $20.65 1 015 862
Aug 26, 2021 $20.98 $21.08 $19.95 $20.11 786 742
Aug 25, 2021 $20.69 $21.50 $20.64 $20.89 1 879 343
Aug 24, 2021 $21.00 $21.00 $20.15 $20.63 735 241
Aug 23, 2021 $20.79 $21.36 $20.64 $20.82 837 147
Aug 20, 2021 $19.50 $20.68 $19.48 $20.64 1 104 179
Aug 19, 2021 $20.21 $20.55 $19.61 $19.68 750 200
Aug 18, 2021 $20.43 $20.98 $20.25 $20.39 723 654
Aug 17, 2021 $20.40 $20.85 $20.06 $20.65 1 160 377
Aug 16, 2021 $20.99 $21.00 $20.06 $20.49 1 789 087
Aug 13, 2021 $20.93 $21.31 $20.36 $20.58 1 511 451
Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... DRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT